Beyond the Data: ORBITA-COSMIC
Mamas Mamas, Rasha Al-Lamee, and Michael Foley discuss treating refractory angina with a coronary sinus reducer.
Mamas Mamas, Rasha Al-Lamee, and Michael Foley discuss treating refractory angina with a coronary sinus reducer.
Background: Systematic reviews are performed manually despite the exponential growth of scientific literature. Objective: To investigate the sensitivity and specificity of GPT-3.5 Turbo, from OpenAI,…
Background: Systematic reviews are performed manually despite the exponential growth of scientific literature. Objective: To investigate the sensitivity and specificity of GPT-3.5 Turbo, from OpenAI,…
Major breakthrough in Alzheimer’s research! Earlier this month, researchers identified specific genetic traits that can cause Alzheimer’s. Watch now on @9new…
Background: Systematic reviews are performed manually despite the exponential growth of scientific literature. Objective: To investigate the sensitivity and specificity of GPT-3.5 Turbo, from OpenAI,…
Background: Systematic reviews are performed manually despite the exponential growth of scientific literature. Objective: To investigate the sensitivity and specificity of GPT-3.5 Turbo, from OpenAI,…
This study presents both qualitative and quantitative evidence of the presence of MPs, and their mass concentrations, polymer types, and physical properties in thrombotic diseases…
Patients with diffuse disease are less likely to see improvements in flow, data from the PPG Global Registry show.
While the AI did fine on multiple-choice questions and could justify its answers, it failed a retest just 2 weeks later.
The first trial to test shortened DAPT in coronary DCBs, REC-CAGEFREE II builds upon the evidence available for DES PCI.
A neutral overall trial result seems to be due to harms in patients with cerebral ischemia and benefits in those with hemorrhages.